US frees up another experimental Ebola drug
Published on Aug 8, 2014 6:06 AM
WASHINGTON (AFP) - US regulators loosened restrictions on a new experimental drug for treating Ebola, which may allow it to be tried on infected patients in West Africa, the company said on Thursday.
The Canada-based company, Tekmira, said the US Food and Drug Administration changed the classification of its drug TKM-Ebola from full clinical hold to partial hold.
"This action enables the potential use of TKM-Ebola in individuals infected with Ebola virus," said a company statement.
Tests on monkeys have shown the drug provided 100 per cent protection from an otherwise lethal dose of Ebola, the company said.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here